Literature DB >> 17164813

Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients.

Morris B Goldman1, Jennifer Gnerlich, Nadeem Hussain.   

Abstract

Schizophrenia, many believe, reflects an enhanced vulnerability to psychological stress. Controlled exposure to stressors, however, has produced inconclusive results, particularly with regards to neurohormones. Some of the variability may be attributable to the nature and psychological significance of the stimulus and failure to control physiologic confounds. In addition, it is possible that the heterogeneity of schizophrenia is an important factor. In a carefully designed study and in a controlled setting, we measured the neuroendocrine response of eight polydipsic hyponatremic (PHS), seven polydipsic normonatremic (PNS), and nine nonpolydipsic normonatremic (NNS) (ie normal water balance) schizophrenic in-patients as well as 12 healthy controls (HC) to two different stressors: one of which appears to influence neuroendocrine secretion through its psychological (cold pressor) and the other (upright posture) through its systemic actions. Subjects in the three psychiatric groups were stabilized and acclimated to the research setting, and all received saline to normalize plasma osmolality. Following the cold pressor, plasma adrenocorticotropin and cortisol levels showed a more prolonged rise in PHS patients relative to PNS patients. NNS patients, in contrast, exhibited blunted responses relative to both of the polydipsic groups and the HC. Peak vasopressin responses were also greater in PHS and blunted in NNS patients. Responses to the postural stimulus were similar across patient groups. These findings provide a mechanism for life threatening water intoxication in schizophrenia; help to reconcile conflicting findings of stress responsiveness in schizophrenia; and potentially identify a discrete patient subset with enhanced vulnerability to psychological stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164813     DOI: 10.1038/sj.npp.1301282

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  12 in total

1.  Structural pathology underlying neuroendocrine dysfunction in schizophrenia.

Authors:  Morris B Goldman; Lei Wang; Carly Wachi; Sheeraz Daudi; John Csernansky; Megan Marlow-O'Connor; Sarah Keedy; Ivan Torres
Journal:  Behav Brain Res       Date:  2010-11-17       Impact factor: 3.332

2.  Fulminant crural compartment syndrome preceded by psychogenic polydipsia.

Authors:  Anton Ulstrup; Randi Ugleholdt; Jeppe Vejlgaard Rasmussen
Journal:  BMJ Case Rep       Date:  2015-05-14

Review 3.  Primary polydipsia: Update.

Authors:  Leeda Ahmadi; Morris B Goldman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-10-14       Impact factor: 4.690

Review 4.  Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases.

Authors:  Margarita Moreno; Pilar Flores
Journal:  Psychopharmacology (Berl)       Date:  2011-11-24       Impact factor: 4.530

5.  Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.

Authors:  Morris B Goldman; Alexandrina M Gomes; C S Carter; Royce Lee
Journal:  Psychopharmacology (Berl)       Date:  2011-02-09       Impact factor: 4.530

Review 6.  The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness.

Authors:  Morris B Goldman
Journal:  Brain Res Rev       Date:  2009-07-09

7.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 8.  Brain circuit dysfunction in a distinct subset of chronic psychotic patients.

Authors:  Morris B Goldman
Journal:  Schizophr Res       Date:  2014-07-01       Impact factor: 4.939

9.  Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.

Authors:  Morris Goldman; Megan Marlow-O'Connor; Ivan Torres; C S Carter
Journal:  Schizophr Res       Date:  2007-10-24       Impact factor: 4.939

Review 10.  A systematic review of the ability of urine concentration to distinguish antipsychotic- from psychosis-induced hyponatremia.

Authors:  Wanlop Atsariyasing; Morris B Goldman
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.